SEC Company Response from Can-Fite BioPharma Ltd. (CANF) (CIK 0001536196) (CANF) — Feb 7, 2020
Can-Fite BioPharma Ltd. (CANF) (CIK 0001536196)
Date: Feb. 7, 2020 · CIK: 0001536196 · Accession: 0001213900-20-002863
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-236064
Letter
Can-Fite BioPharma Ltd.
10 Bareket Street
Kiryat Matalon, P.O. Box 7537
Petach-Tikva 4951778, Israel
February 7, 2020
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Re: Can-Fite BioPharma Ltd.
Registration Statement on Form F-1
File No. 333-236064
VIA EDGAR
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, Can-Fite BioPharma Ltd. (the “Registrant”) hereby respectfully requests that the effectiveness of the Registration Statement on Form F-1 (File No. 333-236064) of the Registrant (the “Registration Statement”) be accelerated so that it will be declared effective at 9:00 a.m., Eastern Time, on February 10, 2020 or as soon thereafter as may be practicable.
The undersigned respectfully requests that it be notified of the effectiveness of the Registration Statement by telephone call to our counsel, McDermott Will& Emery LLP, by calling Gary Emmanuel at (212) 547-5541. The Company hereby authorizes Mr. Emmanuel to orally modify or withdraw this request for acceleration.
Very truly yours,
CAN-FITE BIOPHARMA LTD.
Show Raw Text
CORRESP
1
filename1.htm
Can-Fite BioPharma Ltd.
10 Bareket
Street
Kiryat Matalon,
P.O. Box 7537
Petach-Tikva
4951778, Israel
February 7, 2020
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Re:
Can-Fite BioPharma Ltd.
Registration Statement on Form F-1
File No. 333-236064
VIA EDGAR
Ladies and Gentlemen:
Pursuant to Rule 461 under
the Securities Act of 1933, as amended, Can-Fite BioPharma Ltd. (the “Registrant”) hereby respectfully requests
that the effectiveness of the Registration Statement on Form F-1 (File No. 333-236064) of the Registrant (the “Registration
Statement”) be accelerated so that it will be declared effective at 9:00 a.m., Eastern Time, on February 10, 2020 or
as soon thereafter as may be practicable.
The undersigned respectfully
requests that it be notified of the effectiveness of the Registration Statement by telephone call to our counsel, McDermott Will&
Emery LLP, by calling Gary Emmanuel at (212) 547-5541. The Company hereby authorizes Mr. Emmanuel to orally modify or withdraw
this request for acceleration.
Very truly yours,
CAN-FITE BIOPHARMA LTD.
By:
/s/ Pnina Fishman, Ph.D.
Name: Pnina Fishman, Ph.D.
Title: Chief Executive Officer
cc:
Gary Emmanuel (McDermott Will & Emery LLP)